
Repare Therapeutics RPTX
Quartalsbericht 2025-Q3
hinzugefügt 14.11.2025
Repare Therapeutics P/S 2011-2026 | RPTX
P/S Jährlich Repare Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 10.1 K | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 10.1 K | 10.1 K | 10.1 K |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Autolus Therapeutics plc
AUTL
|
4.27 | $ 1.35 | -2.91 % | $ 359 M | ||
|
Coherus BioSciences
CHRS
|
5.36 | $ 1.61 | -3.59 % | $ 189 M | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
1.96 K | - | 2.54 % | $ 160 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
5.16 | $ 24.88 | -0.4 % | $ 3.04 B | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
2.86 | $ 10.02 | -1.16 % | $ 133 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Cardiff Oncology
CRDF
|
196 | $ 1.57 | -0.63 % | $ 105 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.65 | 1.3 % | $ 8.78 B | ||
|
Advaxis
ADXS
|
144 | - | -9.65 % | $ 45.9 M | ||
|
DBV Technologies S.A.
DBVT
|
500 | $ 20.25 | -0.54 % | $ 2.83 B | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Aytu BioScience
AYTU
|
0.237 | $ 2.55 | -4.14 % | $ 16 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Dyadic International
DYAI
|
10.2 | $ 0.87 | - | $ 31.5 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Entera Bio Ltd.
ENTX
|
83.8 | $ 1.17 | -2.1 % | $ 64 M | ||
|
Equillium
EQ
|
1.77 | $ 2.0 | -0.5 % | $ 115 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
Evogene Ltd.
EVGN
|
71.3 | $ 0.8 | 2.49 % | $ 27.9 M | ||
|
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | ||
|
Fate Therapeutics
FATE
|
28.1 | $ 1.15 | -3.78 % | $ 137 M | ||
|
Forte Biosciences
FBRX
|
181 | $ 26.15 | -1.1 % | $ 339 M | ||
|
Fennec Pharmaceuticals
FENC
|
3.78 | $ 6.2 | -3.43 % | $ 177 M | ||
|
Foghorn Therapeutics
FHTX
|
11.5 | $ 4.75 | -2.59 % | $ 299 M | ||
|
Amicus Therapeutics
FOLD
|
6.98 | $ 14.46 | 0.03 % | $ 4.46 B | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
BioNTech SE
BNTX
|
35.7 | $ 88.37 | -3.19 % | $ 27.2 B | ||
|
Fulcrum Therapeutics
FULC
|
0.00291 | $ 7.45 | -4.85 % | $ 472 K | ||
|
Alnylam Pharmaceuticals
ALNY
|
11 | $ 315.4 | -4.52 % | $ 41.3 B | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Gilead Sciences
GILD
|
6.23 | $ 138.37 | -1.26 % | $ 172 B | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
73.3 | $ 0.54 | 4.26 % | $ 503 K | ||
|
Genmab A/S
GMAB
|
15.6 | $ 27.13 | -2.25 % | $ 17 B |